Natural cubic splines for the analysis of Alzheimer's clinical trials

Overview of attention for article published in Pharmaceutical Statistics, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 580)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 1 news outlet

twitter: 24 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 15 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 26 X posts from 24 X users, with an upper bound of 73,363 followers.

RT @StatisticsViews: Read this newly published Open Access article from Pharmaceutical Statistics: Natural cubic splines for the analysis o…

14 Feb 2023

Reply Repost Favourite

Read this newly published Open Access article from Pharmaceutical Statistics: Natural cubic splines for the analysis of Alzheimer’s clinical trials (Donohue et al) https://t.co/GGA1eyH4T0 https://t.co/l5ZY0W4e8W @PSIupdate

13 Feb 2023

Reply Repost Favourite

Natural cubic splines for the analysis of Alzheimer's clinical trials https://t.co/W20KQG6PuY Mixed model repeated measures (MMRM) is a common analysis method used for Alzheimer's disease that treats time as a categorical variable. But this categorization

19 Jan 2023

Reply Repost Favourite

RT @Wiley_Stats: Check out this article from Pharmaceutical Statistics titled "Natural cubic splines for the analysis of Alzheimer's clinic…

19 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 22 additional X posts.